Posts
LFVN might be one of the most overlooked short squeeze setups in the market right now.
The numbers here are honestly wild for a company this small. Current short interest is sitting around 3.85 million shares, which is roughly 39% to 44% of the float depending on the source. That is an insanely high percentage for a low float stock. Days to cover is currently around …
How long will we hold LFVN? Tell me your price targets… No financial advice
Ready for the day but not sure if I should Place a stop loss?
GRPN: 13.72M shares short against ~8.9M loanable. Two months at 100% utilization. The math keeps getting worse.
Hello again. Two weeks ago I posted a breakdown of GRPN's ownership stack showing \~45% of shares are locked by strategic holders who won't lend, short interest was 13.87M against an estimated \~8.9M loanable supply, and borrow utilization was sitting at 156% of available shares. I'm back with an update. …
LVFN the fire is up and we will hopefully see that thing squeeeeeeeze
No financial advice but this could be the start 🛫
GRPN price action is bullish $25 inbound.
Last weeks post got deleted by mods. Apparently it was NSFW…. HOWEVER TO KEEP THINGS CLEAN ALL ILL SAY IS GRPN price action today is extremely bullish. Shorts doubled down this morning and longs absorbed it instantly. Looking for a late-day rally into a strong close. Volume nearly doubled today …
$PHGE looks really primed for a squeeze
Look $PHGE went to 2.7 pre market and have faded down since then. From 1 day to next the Borrow fee have went from 130.1 to 341.66. I have watched the tape closely since like 1 hour before open market. The keypoint here is 1.6, it have been several hard …
LFVN - this may be the time! Over $6
This things a powder keg waiting to blow. I’ve been holding calls since 5/2 and I can confidently say this is the most momentum I’ve seen. We are also getting close to dividend date (6/15) so between the cost to borrow, dividend, momentum, and days to cover.. this thing could …
BLRX: $12M market cap brain cancer drug, earnings Wednesday, ASCO Friday, 3.62% short float. Quietly loading
I’d imagine most of you have never heard of $BLRX, but this week can put it on a lot of retail’s radar. First patient just dosed in a first-in-human glioblastoma trial. First-in-class mechanism. Works where nothing else does including TMZ-resistant patients. Two abstracts accepted at ASCO 2026 opening this Friday. …
LFVN - 43.11% shorted, 105% borrow rate, 45 DTC
Fintel stopped updating for a week, but these are the most recent numbers now. June 1st LFVN is paying a .05 dividend per share. Announced stock repurchase sometime in the future during last earnings. Profitable company. Invest at your own risk. Statistics do not guarantee the price going up or …
Not to forget $NOK too, let's enjoy the ride up!
We could possibly see 50 by EOY! Let's enjoy the ride up!! https://preview.redd.it/xmzw0k1j6a3h1.jpg?width=1080&format=pjpg&auto=webp&s=6d3939065728ba7892589e204d37a9dc6179ebfd